Related Experiment Videos
Potentiative interactions between caffeine and various teratogenic agents
Teratology
|February 1, 1982
Summary
Caffeine potentiates the embryotoxic effects of various drugs in rats, even at doses that are otherwise minimally harmful. Further research is needed to determine if human-level caffeine consumption poses similar risks.
Area of Science:
- Developmental toxicology
- Pharmacology
- Teratology
Background:
- Acetazolamide and inhibitors of nucleic acid and protein synthesis are known to have varying degrees of embryotoxicity.
- Caffeine is a widely consumed substance with potential biological effects.
Purpose of the Study:
- To investigate the potential synergistic embryotoxic effects of caffeine when co-administered with other teratogenic agents.
- To assess the impact of caffeine on the toxicity profiles of DNA, RNA, and protein synthesis inhibitors in pregnant rats.
Main Methods:
- Pregnant rats were administered acetazolamide or inhibitors of DNA synthesis (hydroxyurea, 5-fluoro-2'-deoxyuridine), RNA synthesis (actinomycin D), or protein synthesis (cycloheximide, emetine).
- These agents were co-administered with caffeine at doses that individually caused minimal embryotoxicity.
- Embryonic development and toxicity were assessed following the combined treatments.
Main Results:
- Co-administration of caffeine with any of the tested agents (acetazolamide, DNA, RNA, or protein synthesis inhibitors) resulted in a significant potentiation of embryotoxicity.
- Each tested agent alone, at the administered doses, induced only minimal embryotoxicity.
Conclusions:
- Caffeine exhibits a powerful potentiative effect on the embryotoxicity of various agents, including acetazolamide and inhibitors of essential cellular synthesis pathways.
- The findings suggest a potential risk of enhanced developmental toxicity when caffeine is consumed concurrently with certain medications, although human-relevant dosages require further investigation.